- Home
- XWEL vs GLTO Comparison
XWEL vs GLTO Comparison
Compare XWEL & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XWEL
- GLTO
- Stock Information
- Founded
- XWEL 2006
- GLTO 2011
- Country
- XWEL United States
- GLTO Denmark
- Employees
- XWEL N/A
- GLTO N/A
- Industry
- XWEL Other Consumer Services
- GLTO Biotechnology: Pharmaceutical Preparations
- Sector
- XWEL Consumer Discretionary
- GLTO Health Care
- Exchange
- XWEL Nasdaq
- GLTO Nasdaq
- Market Cap
- XWEL 5.7M
- GLTO 6.5M
- IPO Year
- XWEL N/A
- GLTO 2020
- Fundamental
- Price
- XWEL $0.97
- GLTO $3.23
- Analyst Decision
- XWEL
- GLTO Buy
- Analyst Count
- XWEL 0
- GLTO 1
- Target Price
- XWEL N/A
- GLTO $10.00
- AVG Volume (30 Days)
- XWEL 95.1K
- GLTO 719.8K
- Earning Date
- XWEL 05-14-2025
- GLTO 03-19-2025
- Dividend Yield
- XWEL N/A
- GLTO N/A
- EPS Growth
- XWEL N/A
- GLTO N/A
- EPS
- XWEL N/A
- GLTO N/A
- Revenue
- XWEL $33,833,000.00
- GLTO N/A
- Revenue This Year
- XWEL $22.75
- GLTO N/A
- Revenue Next Year
- XWEL N/A
- GLTO N/A
- P/E Ratio
- XWEL N/A
- GLTO N/A
- Revenue Growth
- XWEL 11.79
- GLTO N/A
- 52 Week Low
- XWEL $0.74
- GLTO $2.79
- 52 Week High
- XWEL $2.70
- GLTO $19.75
- Technical
- Relative Strength Index (RSI)
- XWEL 43.40
- GLTO 40.83
- Support Level
- XWEL $0.95
- GLTO $2.79
- Resistance Level
- XWEL $1.33
- GLTO $7.30
- Average True Range (ATR)
- XWEL 0.20
- GLTO 0.78
- MACD
- XWEL 0.01
- GLTO -0.17
- Stochastic Oscillator
- XWEL 30.77
- GLTO 9.76
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.
About GLTO Galecto Inc.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.